Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.

IF 38.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Circulation Pub Date : 2025-03-04 Epub Date: 2025-02-05 DOI:10.1161/CIRCULATIONAHA.124.071153
Sandeep Arunothayaraj, Mohaned Egred, Adrian P Banning, Philippe Brunel, Miroslaw Ferenc, Thomas Hovasse, Adrian Wlodarczak, Manuel Pan, Thomas Schmitz, Marc Silvestri, Andreis Erglis, Evgeny Kretov, Jens Flensted Lassen, Alaide Chieffo, Thierry Lefèvre, Francesco Burzotta, James Cockburn, Olivier Darremont, Goran Stankovic, Marie-Claude Morice, Yves Louvard, David Hildick-Smith
{"title":"Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.","authors":"Sandeep Arunothayaraj, Mohaned Egred, Adrian P Banning, Philippe Brunel, Miroslaw Ferenc, Thomas Hovasse, Adrian Wlodarczak, Manuel Pan, Thomas Schmitz, Marc Silvestri, Andreis Erglis, Evgeny Kretov, Jens Flensted Lassen, Alaide Chieffo, Thierry Lefèvre, Francesco Burzotta, James Cockburn, Olivier Darremont, Goran Stankovic, Marie-Claude Morice, Yves Louvard, David Hildick-Smith","doi":"10.1161/CIRCULATIONAHA.124.071153","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European Bifurcation Club Left Main Trial) aimed to evaluate clinical outcomes of a stepwise provisional strategy compared with a systematic dual-stent approach.</p><p><strong>Methods: </strong>EBC MAIN was a randomized, investigator-initiated, open-label, multicenter, parallel-group trial conducted across 35 hospitals in 11 European countries. A total of 467 participants undergoing percutaneous coronary intervention for unprotected true left main bifurcation lesions were randomly assigned to the stepwise provisional strategy (n=230) or an upfront dual-stent approach (n=237). The mean (SD) age was 71 (10) years and 23% of participants were women. The primary end point was a composite of major adverse cardiac events, defined as all-cause mortality, all myocardial infarction, or clinically driven target lesion revascularization. Events were adjudicated by an independent clinical events committee and all analyses were by the intention-to-treat principle.</p><p><strong>Results: </strong>At 3 years, the primary end point occurred in 54 of 230 (23.5%) stepwise provisional and 70 of 237 (29.5%) dual-stent patients (hazard ratio, 0.75 [95% CI, 0.53-1.07]; <i>P</i>=0.11). There was no significant difference in all-cause mortality (10.0% versus 13.1%) or myocardial infarction (12.2% versus 11.0%). However, target lesion revascularization was significantly lower in the stepwise provisional group (8.3% versus 15.6%; hazard ratio, 0.50 [95% CI, 0.29-0.86]; <i>P</i>=0.013). In this population, the mean side vessel diameter by quantitative angiography was 2.9 mm, and median side vessel lesion length was 5 mm. Significant interactions were identified between the assigned bifurcation strategy and both side vessel diameter and lesion length with respect to the primary outcome (<i>P</i>=0.009 and <i>P</i>=0.005, respectively), with smaller vessels (<3.25 mm diameter) and shorter lesions (<10 mm length) favoring the provisional approach.</p><p><strong>Conclusions: </strong>In a European population with true left main stem bifurcation coronary disease requiring intervention, there was no difference in major adverse cardiovascular events between stepwise provisional and systematic dual-stent strategies at 3 years. Target lesion revascularization was significantly less frequent with the stepwise provisional approach, which should be the default strategy for noncomplex left main bifurcation coronary intervention.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT02497014.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":"612-622"},"PeriodicalIF":38.6000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCULATIONAHA.124.071153","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European Bifurcation Club Left Main Trial) aimed to evaluate clinical outcomes of a stepwise provisional strategy compared with a systematic dual-stent approach.

Methods: EBC MAIN was a randomized, investigator-initiated, open-label, multicenter, parallel-group trial conducted across 35 hospitals in 11 European countries. A total of 467 participants undergoing percutaneous coronary intervention for unprotected true left main bifurcation lesions were randomly assigned to the stepwise provisional strategy (n=230) or an upfront dual-stent approach (n=237). The mean (SD) age was 71 (10) years and 23% of participants were women. The primary end point was a composite of major adverse cardiac events, defined as all-cause mortality, all myocardial infarction, or clinically driven target lesion revascularization. Events were adjudicated by an independent clinical events committee and all analyses were by the intention-to-treat principle.

Results: At 3 years, the primary end point occurred in 54 of 230 (23.5%) stepwise provisional and 70 of 237 (29.5%) dual-stent patients (hazard ratio, 0.75 [95% CI, 0.53-1.07]; P=0.11). There was no significant difference in all-cause mortality (10.0% versus 13.1%) or myocardial infarction (12.2% versus 11.0%). However, target lesion revascularization was significantly lower in the stepwise provisional group (8.3% versus 15.6%; hazard ratio, 0.50 [95% CI, 0.29-0.86]; P=0.013). In this population, the mean side vessel diameter by quantitative angiography was 2.9 mm, and median side vessel lesion length was 5 mm. Significant interactions were identified between the assigned bifurcation strategy and both side vessel diameter and lesion length with respect to the primary outcome (P=0.009 and P=0.005, respectively), with smaller vessels (<3.25 mm diameter) and shorter lesions (<10 mm length) favoring the provisional approach.

Conclusions: In a European population with true left main stem bifurcation coronary disease requiring intervention, there was no difference in major adverse cardiovascular events between stepwise provisional and systematic dual-stent strategies at 3 years. Target lesion revascularization was significantly less frequent with the stepwise provisional approach, which should be the default strategy for noncomplex left main bifurcation coronary intervention.

Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02497014.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
逐步临时与系统双支架治疗真左主干冠状动脉分叉病变的策略。
背景:真正的左主干分叉病变的最佳冠状动脉支架置入技术是不确定的。EBC MAIN(欧洲分支俱乐部左主干试验)旨在评估逐步临时策略与系统双支架方法的临床结果。方法:EBC MAIN是一项随机、研究者发起、开放标签、多中心、平行组试验,在11个欧洲国家的35家医院进行。共有467名接受经皮冠状动脉介入治疗无保护的真左主干分叉病变的参与者被随机分配到逐步临时策略(n=230)或预先双支架入路(n=237)。平均(SD)年龄为71(10)岁,23%的参与者为女性。主要终点是主要心脏不良事件的综合,定义为全因死亡率、全心肌梗死或临床驱动的靶病变血运重建术。事件由独立的临床事件委员会裁决,所有分析均遵循意向治疗原则。结果:在3年时,230例逐步临时支架患者中有54例(23.5%)出现了主要终点,237例双支架患者中有70例(29.5%)出现了主要终点(风险比为0.75 [95% CI, 0.53-1.07];P = 0.11)。全因死亡率(10.0%对13.1%)和心肌梗死(12.2%对11.0%)无显著差异。然而,在逐步过渡组中,目标病变血运重建率明显较低(8.3% vs 15.6%;风险比,0.50 [95% CI, 0.29-0.86];P = 0.013)。在这个人群中,定量血管造影显示的平均侧血管直径为2.9 mm,中位侧血管病变长度为5 mm。就主要结局而言,指定的分叉策略与双侧血管直径和病变长度之间存在显著的相互作用(分别为P=0.009和P=0.005),对于较小的血管(结论:在需要干预的真正左主干分叉冠状动脉疾病的欧洲人群中,分步临时和系统双支架策略在3年的主要不良心血管事件方面没有差异。对于非复杂左主干分叉冠状动脉介入治疗而言,逐步临时入路的目标病变血运重建率明显较低。注册:网址:https://www.clinicaltrials.gov;唯一标识符:NCT02497014。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Circulation
Circulation 医学-外周血管病
CiteScore
45.70
自引率
2.10%
发文量
1473
审稿时长
2 months
期刊介绍: Circulation is a platform that publishes a diverse range of content related to cardiovascular health and disease. This includes original research manuscripts, review articles, and other contributions spanning observational studies, clinical trials, epidemiology, health services, outcomes studies, and advancements in basic and translational research. The journal serves as a vital resource for professionals and researchers in the field of cardiovascular health, providing a comprehensive platform for disseminating knowledge and fostering advancements in the understanding and management of cardiovascular issues.
期刊最新文献
JNK2 Is a Stress Integrator Driving Atrial Fibrillation Pathogenesis in Aging via Gut-Heart Crosstalk. The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis. Targeting E3 Ubiquitin Ligase Hrd1 Prevents Myocardial Ischemia-Reperfusion Injury Through Enhancing ALDH2 Enzymatic Activity. WNT5a-Mediated Aberrant Actin Filament Dynamics Drive Cardiac Pathogenic Phenotypes in LMNA-Related Emery-Dreifuss Muscular Dystrophy. Targeting Interleukin-8-Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1